Retrospective and Prospective Database of COVID-19 prevalence and clinical course in pediatric and young adult Hematology/Oncology/Stem Cell Therapy patients in the Tri-State Area (Pediatric HOT COVID Database)
Sponsor: |
Columbia University |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAT0268 |
U.S. Govt. ID: |
NCT04445402 |
Contact: |
Jean Sosna, RN: 212-305-2050 / js4403@cumc.columbia.edu |
The COVID-19 Hematology, Oncology, Stem Cell Transplant (HOT) Consortium of Greater New York City is trying to learn more about the effects of COVID-19 on hemoglobinopathies, immunodeficiencies and cancer in children and young adults. Although exact studies for which the Research Database data may be used are not known at this time, the following are types of studies in which these data may be included are: 1) Studies to determine how well people recover from a COVID-19 infection, 2) Studies on how recovery after COVID-19 can be improved, 3) Studies to look at how various demographic and socioeconomic factors affect COVID-19 infection and recovery, 4) Studies to examine the effect of COVID-19 on other diagnoses, 5) Studies to determine if COVID-19 related delays to other planned treatment affected patients adversely.
This study is closed
Investigator
Prakash Satwani, MD
Is the patient 21 years of age or younger? |
Yes |
No |
Was the patient tested for COVID-19 in the tri-state area (New York, New Jersey, Connecticut)? |
Yes |
No |
Is the patient under the care of a pediatric Oncologist, Hematologist or Stem Cell Transplant doctor for a medical condition? |
Yes |
No |